Oncotelic Therapeutics, Inc.
OTLC- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000908259
No open-market purchases or sales by Oncotelic Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Oncotelic Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 61.2K | +61.2K |
| Value | $0 | $12.0K | +$12.0K |
New holders (1)
Institutions that held Oncotelic Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 61,196 | $12.0K | 0.00% |
Sold out (0)
Institutions that held Oncotelic Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.